The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 26, Issue 8, Pages 1101-1110
Publisher
Springer Nature
Online
2013-03-22
DOI
10.1038/modpathol.2013.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Profile of Grade 3 Endometrioid Endometrial Carcinoma
- (2012) Teresa Alvarez et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Diagnosis of Endometrial Carcinomas With Clear Cells by Gynecologic Pathologists
- (2012) Oluwole Fadare et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
- (2012) Munmun Rahman et al. HUMAN PATHOLOGY
- Histological Grading of Ovarian Clear Cell Adenocarcinoma
- (2012) Sohei Yamamoto et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Endometrial carcinoma: molecular alterations involved in tumor development and progression
- (2012) A Yeramian et al. ONCOGENE
- Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
- (2012) Dan-dan Wang et al. PLoS One
- Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment
- (2012) Oluwole Fadare et al. Journal of Cancer
- Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
- (2011) Bin Guan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance
- (2011) Xianyu Zhang et al. Cancer Epidemiology
- ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
- (2011) B. Guan et al. CANCER RESEARCH
- Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance
- (2011) W Glenn McCluggage et al. HISTOPATHOLOGY
- Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
- (2011) Siân Jones et al. HUMAN MUTATION
- Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers
- (2011) William J. Lowery et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
- (2011) Kimberly C Wiegand et al. JOURNAL OF PATHOLOGY
- PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. VIRCHOWS ARCHIV
- High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes
- (2010) Abdulmohsen Alkushi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
- (2010) Daichi Maeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E
- (2010) Y Xu et al. ONCOGENE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Endometrial carcinomas with ambiguous features
- (2010) Robert A. Soslow SEMINARS IN DIAGNOSTIC PATHOLOGY
- HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A
- (2009) Capucine Van Rechem et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Management of women with clear cell endometrial cancer
- (2009) Alexander B. Olawaiye et al. GYNECOLOGIC ONCOLOGY
- p53 alteration independently predicts poor outcomes in patients with endometrial cancer: A clinicopathologic study of 131 cases and literature review
- (2009) Eun-Ju Lee et al. GYNECOLOGIC ONCOLOGY
- Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation inSnf5+/â;p53+/âmice
- (2009) Jessica DelBove et al. MOLECULAR CARCINOGENESIS
- The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells
- (2009) S R Naidu et al. ONCOGENE
- The SWI/SNF complex and cancer
- (2009) D Reisman et al. ONCOGENE
- Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma
- (2008) L. Jia et al. CLINICAL CANCER RESEARCH
- Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage
- (2008) Ji-Hye Park et al. DNA REPAIR
- SWI/SNF: A chromatin-remodelling complex with a role in carcinogenesis
- (2008) Gary M. Halliday et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The SWI/SNF Chromatin-Remodeling Complex and Glucocorticoid Resistance in Acute Lymphoblastic Leukemia
- (2008) Nicolas Pottier et al. JNCI-Journal of the National Cancer Institute
- The genetics of the p53 pathway, apoptosis and cancer therapy
- (2008) Alexei Vazquez et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started